z-logo
Premium
Terminal complement inhibition dampens the inflammation during COVID‐19
Author(s) -
Kulasekararaj Austin G.,
Lazana Ioanna,
Large Joanna,
Posadas Kristina,
Eagleton Helen,
Lord Villajin John,
Zuckerman Mark,
Gandhi Shreyans,
Marsh Judith C. W.
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16916
Subject(s) - eculizumab , haemolysis , cd59 , immunology , medicine , complement system , complement component 5 , paroxysmal nocturnal hemoglobinuria , complement membrane attack complex , antibody

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom